Management of poor ovarian responders in IVF
Tóm tắt
Từ khóa
Tài liệu tham khảo
Adashi, 1985, Insulin-like growth factors as intraovarian regulators of granulosa cell growth and function, Endocrine Reviews, 6, 400, 10.1210/edrv-6-3-400
Akande, 2002, Biological versus chronological ageing of oocytes, distinguishable by raised FSH levels in relation to the success of IVF treatment, Human Reproduction, 17, 2003, 10.1093/humrep/17.8.2003
Akman, 2000, Addition of GnRH antagonist in cycles of poor responders undergoing IVF, Human Reproduction, 15, 2145, 10.1093/humrep/15.10.2145
Akman, 2001, Comparison of agonistic flare-up-protocol and antagonistic multiple dose protocol in ovarian stimulation of poor responders: results of a prospective randomized trial, Human Reproduction, 16, 868, 10.1093/humrep/16.5.868
Albano, 1997, Comparison of different doses of gonadotropin-releasing hormone antagonist cetrorelix during controlled ovarian hyperstimulation, Fertility and Sterility, 67, 917, 10.1016/S0015-0282(97)81407-0
Bancsi, 2002, Predictors of poor ovarian response in in-vitro fertilization: a prospective study comparing basal markers of ovarian reserve, Fertiity and Sterility, 77, 328, 10.1016/S0015-0282(01)02983-1
Baricca, 1993, In vivo and in vitro effect of growth hormone on estradiol secretion by granulosa cells, Journal of Clinical Endocrinology and Metabolism, 77, 61, 10.1210/jc.77.1.61
Barnhart, 2002, Effect of endometriosis on in vitro fertilization, Fertility and. Sterility, 77, 1148, 10.1016/S0015-0282(02)03112-6
Battaglia, 1996, Influence of maternal age on meiotic spindle assembly in oocytes from naturally cycling women, Human Reproduction, 11, 2217, 10.1093/oxfordjournals.humrep.a019080
Battaglia, 1999, Adjuvant l-arginine treatment for in-vitro fertilization in poor responder patients, Human Reproduction, 14, 1690, 10.1093/humrep/14.7.1690
Bassil, 1999, Outcome of in-vitro fertilization through natural cycles in poor responders, Human Reproduction, 14, 1262, 10.1093/humrep/14.5.1262
Benadiva, 1996, Aneuploidy 16 in human embryos increases significantly with maternal age, Fertility and Sterility, 66, 248, 10.1016/S0015-0282(16)58448-9
Blumenfeld, 1994, Growth hormone co-treatment for ovulation induction may enhance conception in the co-treatment and succeeding cycles in clonidine negative but not clonidine positive patients, Human Reproduction, 9, 209, 10.1093/oxfordjournals.humrep.a138483
Brook, 1984, Maternal ageing and aneuploidy embryos: evidence from the mouse that biological and not chronological age is the important influence, Human Genetics, 66, 41, 10.1007/BF00275184
Brown, 1995, Variability of day 3 follicle-stimulating hormone levels in eumenorrheic women, Journal of Reproductive Medicine, 40, 620
Brzyski, 1988, Follicular atresia associated with concurrent initiation of gonadotropin-releasing hormone agonist and follicle-stimulating hormone for oocyte recruitment, Fertility and Sterility, 50, 917, 10.1016/S0015-0282(16)60372-2
Burger, 1998, Serum inhibins A and B fall differentially as FSH rises in perimenopausal women, Clinical Endocrinology (Oxford), 48, 809, 10.1046/j.1365-2265.1998.00482.x
Burns, 1996, Diminished alpha-inhibin messenger ribonucleic acid in in vitro fertilization–embryo transfer poor responders reflects declining follicle reserve, Fertility and Sterility, 65, 394, 10.1016/S0015-0282(16)58106-0
Cahill, 1994, Relative influence of serum follicle stimulating hormone, age and other factors on ovarian response to gonadotrophin stimulation, British Journal of Obstetrics and Gynaecology, 101, 999, 10.1111/j.1471-0528.1994.tb13047.x
Cameron, 1988, Occult ovarian failure: a syndrome of infertility, regular menses, and elevated follicle-stimulating hormone concentrations, Journal of Clinical Endocrinology and Metabolism, 67, 1190, 10.1210/jcem-67-6-1190
Chuang, 2003, Age is a better predictor of pregnancy potential than basal FSH levels in women undergoing in vitro fertilization, Fertility and Sterility, 79, 63, 10.1016/S0015-0282(02)04562-4
Copperman, 2003, Antagonists in poor responder patients, Fertility and Sterility, 80, 16, 10.1016/S0015-0282(03)00765-9
Craft, 1999, Will GnRH antagonist provide a new hope for patients considered ‘difficult responders’ to GnRH agonist protocols?, Human Reproduction, 14, 2959, 10.1093/humrep/14.12.2959
Creus, 2000, Day 3 serum inhibin B and FSH and age as predictors of assisted reproduction treatment outcome, Human Reproduction, 15, 2341, 10.1093/humrep/15.11.2341
D'Amato, 2004, A novel protocol of ovulation induction with delayed gonadotropin-releasing hormone antagonist administration combined with high-dose recombinant follicle-stimulating hormone and clomiphene citrate for poor responders and women over 35 years, Fertility and Sterility, 81, 1572, 10.1016/j.fertnstert.2004.01.022
Davoren, 1986, Growth hormone increases ovarian levels of immunoreactive somatomedin-C/insulin-like growth factor I in vivo, Endocrinology, 118, 888, 10.1210/endo-118-2-888
De Placido, 2000, Recombinant FSH is effective in poor responder patients to highly purified FSH, Human Reproduction, 15, 17, 10.1093/humrep/15.1.17
De Vet, 2002, Antimullerian hormone serum levels: a putative marker for ovarian ageing, Fertility and Sterility, 77, 357, 10.1016/S0015-0282(01)02993-4
Deaton, 1996, Pituitary response to early follicular phase minidose gonadotropin releasing hormone agonist (GnRH-a) therapy: evidence for a second flare, Journal of Assisted Reproduction and Genetics, 13, 390, 10.1007/BF02066170
Dechaud, 1998, Obesity and assisted reproduction techniques, Contraception, Fertility and Sex, 26, 564
Dirnfeld, 1999, Cessation of gonadotropin-releasing hormone analogue (GnRH-a) upon down-regulation versus conventional long GnRH-a protocol in poor-responders undergoing in vitro fertilization, Fertility Sterility, 72, 406, 10.1016/S0015-0282(99)00289-7
Dor, 1992, The prognostic importance of the number of oocytes retrieved and estradiol levels in poor and normal responders in in vitro fertilization (IVF) treatment, Journal of Assisted Reproduction and Genetics, 9, 228, 10.1007/BF01203818
Ebbiary, 1994, Hypothalamic-pituitary ageing: progressive increase in FSH and LH concentrations throughout the reproductive life in regularly menstruating women, Clinical Endocrinology (Oxford), 41, 199, 10.1111/j.1365-2265.1994.tb02530.x
Edelstein, 1999, Equivalency of human menopausal gonadotropin and follicle-stimulating hormone stimulation after gonadotropin-releasing hormone agonist suppression, Fertility and Sterility, 53, 103, 10.1016/S0015-0282(16)53224-5
El-Nemr, 1998, Effect of smoking on ovarian reserve and ovarian stimulation in in-vitro fertilization and embryo transfer, Human Reproduction, 13, 2192, 10.1093/humrep/13.8.2192
El-Toukhy, 2002, Young age does not protect against the adverse effects of reduced ovarian reserve – an eight year study, Human Reproduction, 17, 1519, 10.1093/humrep/17.6.1519
Engel, 2001, Inhibin A/B in HMG or recombinant FSH ovarian stimulation with cetrorelix medication, Reproductive BioMedicine Online, 3, 104, 10.1016/S1472-6483(10)61976-1
Faber, 1998, Cessation of gonadotropin-releasing hormone agonist therapy combined with high-dose gonadotropin stimulation yields favorable pregnancy results in low responders, Fertility and Sterility, 69, 826, 10.1016/S0015-0282(98)00040-5
Faddy, 1992, Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause, Human Reproduction, 7, 1342, 10.1093/oxfordjournals.humrep.a137570
Fanchin, 1994, Exogenous follicle stimulating hormone ovarian reserve test (EFORT): a simple and reliable screening test for detecting ‘poor responders’ in in-vitro fertilization, Human Reproduction, 9, 1607, 10.1093/oxfordjournals.humrep.a138760
Fasouliotis, 2003, GnRH-antagonist versus GnRH-agonist in ovarian stimulation of poor responders undergoing IVF, Journal Assisted Reproduction and Genetics, 20, 455, 10.1023/B:JARG.0000006707.88826.e7
Feldberg, 1994, Minidose gonadotropin releasing hormone agonist is the treatment of choice in poor responders with high follicle-stimulating hormone levels, Fertility and Sterility, 62, 343, 10.1016/S0015-0282(16)56889-7
Freeman, 2000, Women with reduced ovarian complement may have an increased risk for a child with Down syndrome, American Journal Human Genetics, 66, 1680, 10.1086/302907
Fridstrom, 1997, Serum levels of luteinizing and follicle-stimulating hormones in normal and poor-responding patients undergoing ovarian stimulation with urofollitropin after pituitary down regulation, Gynecological Endocrinology, 11, 25, 10.3109/09513599709152313
Garcia-Velasco, 2000, High doses of gonadotrophins combined with stop versus non-stop protocol of GnRH analogue administration in low responder IVF patients: a prospective, randomized controlled trial, Human Reproduction, 15, 2292, 10.1093/humrep/15.11.2292
Gelety, 1995, Short-term endocrine response to gonadotropin-releasing hormone agonist initiated in the early follicular, mid luteal or late luteal phase in normally cycling women, Fertility and Sterility, 64, 1074, 10.1016/S0015-0282(16)57963-1
Gougeon, 1996, Regulation of ovarian follicular development in primates: facts and hypotheses, Endocrine Reviews, 17, 121, 10.1210/edrv-17-2-121
Groome, 1996, Measurement of dimeric inhibin B throughout the human menstrual cycle, Journal of Clinical Endocrinology and Metabolism, 81, 1401, 10.1210/jc.81.4.1401
Hardy, 1999, Reproductive characteristics and the age at the inception of the perimenopause in a British National Cohort, American Journal of Epidemiology, 149, 612, 10.1093/oxfordjournals.aje.a009861
Hofmann, 1989, High-dose follicle-stimulating hormone (FSH) ovarian stimulation in low-responder patients for in vitro fertilization, Journal of In Vitro Fertilization and Embryo Transfer, 6, 285, 10.1007/BF01139183
Hofmann, 1996, Efficacy of selection criteria of ovarian reserve screening using the clomiphene citrate challenge test in a tertiary fertility centre population, Fertility and Sterility, 66, 49, 10.1016/S0015-0282(16)58386-1
Howles, 1987, Short term use of an LHRH agonist to treat poor responders entering an in-vitro fertilization programme, Human Reproduction, 2, 655, 10.1093/oxfordjournals.humrep.a136610
Hsu, 1988, Concomitant effects of growth hormone on secretion of insulin-like growth factor I and progesterone by cultured porcine granulosa cells in vitro, Endocrinology, 120, 198, 10.1210/endo-120-1-198
Hughes, 1992, The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer: a meta-analysis of randomized controlled trials, Fertility and Sterility, 58, 888, 10.1016/S0015-0282(16)55430-2
Hughes, 1994, A double-blind crossover controlled study to evaluate the effect of biosynthetic growth hormone on ovarian stimulation in previous poor responders to in-vitro fertilization, Human Reproduction, 9, 13, 10.1093/oxfordjournals.humrep.a138301
Hugues, 1991, Interest of growth hormone-releasing hormone administration for improvement of ovarian responsiveness to gonadotropins in poor responder women, Fertility and Sterility, 55, 945, 10.1016/S0015-0282(16)54304-0
Hurst, 1992, Use of granulosa–luteal cell culture to evaluate low and high clinical responses to menotropin stimulation, Journal of Endocrinological Investigation, 15, 567, 10.1007/BF03344926
Ibrahim, 1991, The use of biosynthetic human growth hormone to augment ovulation induction in buserelin acetate/human menopausal gonadotropin in women with a poor ovarian response, Fertility and Sterility, 55, 202, 10.1016/S0015-0282(16)54084-9
Jia, 1986, Growth hormone enhances follicle-stimulating hormone-induced differentiation of cultured rat granulosa cells, Endocrinology, 118, 1401, 10.1210/endo-118-4-1401
Kailasam, 2004, Defining poor ovarian response during IVF cycles, in women aged <40 years, and its relationship with treatment outcome, Human Reproduction, 19, 1544, 10.1093/humrep/deh273
Karande, 1999, A rational approach to the management of low responders in IVF, Human Reproduction, 14, 1744, 10.1093/humrep/14.7.1744
Karande, 1990, High-dose follicle-stimulating hormone stimulation at the onset of the menstrual cycle does not improve the in vitro fertilization outcome in low-responder patients, Fertility and Sterility, 53, 486, 10.1016/S0015-0282(16)53345-7
Karande, 1997, Limited success using the ‘flare’ protocol in poor responders in cycles with low basal follicle-stimulating hormone levels during in vitro fertilization, Fertility and Sterility, 67, 900, 10.1016/S0015-0282(97)81403-3
Keay, 1997, Assisted conception following poor ovarian response to gonadotrophin stimulation, British Journal of Obstetrics and Gynecology, 104, 521, 10.1111/j.1471-0528.1997.tb11525.x
Keay, 1998, Could ovarian infection impair ovarian response to gonadotrophin stimulation?, British Journal of Obstetrics and Gynaecology, 105, 252, 10.1111/j.1471-0528.1998.tb10082.x
Keefe, 1995, Mitochondrial deoxyribonucleic acid deletions in oocytes and reproductive aging in women, Fertility and Sterility, 64, 577, 10.1016/S0015-0282(16)57796-6
Kenisberg, 1984, Medical hypophysectomy II: Variability of ovarian response to gonadotrophin therapy, Fertility Sterility, 42, 116, 10.1016/S0015-0282(16)47969-0
Klein, 1996, Decreased inhibin B secretion is associated with the monotropic FSH rise in older, ovulatory women: a study of serum and follicular fluid levels of dimeric inhibin A and B in spontaneous menstrual cycles, Journal of Clinical Endocrinology and Metabolism, 81, 2742, 10.1210/jc.81.7.2742
Kolibianakis, 2004, Modified natural cycles for IVF does not offer a realistic chance of parenthood in poor responders with high day 3 FSH levels, as a last resort prior to oocyte donation, Human Reproduction, 19, 2545, 10.1093/humrep/deh452
Kowalik, 1998, Ovarian estradiol production in vivo: inhibitory effect of leuprolide acetate, Journal of Reproductive Medicine, 43, 413
Lamb, 1997, Characterization of susceptible chiasma configurations that increase the risk of maternal non-disjunction of chromosome 21, Human Molecular Genetics, 6, 1391, 10.1093/hmg/6.9.1391
Land, 1996, High-dose human menopausal gonadotropin stimulation in poor responders does not improve in vitro fertilization outcome, Fertility and Sterility, 65, 961, 10.1016/S0015-0282(16)58269-7
Lashen, 1999, Poor responders to ovulation induction: is proceeding to in-vitro fertilization worthwhile?, Human Reproduction, 14, 964, 10.1093/humrep/14.4.964
Leondires, 1999, Microdose follicular phase gonadotropin-releasing hormone agonist (GnRH-a) compared with luteal phase GnRH-a for ovarian stimulation at in vitro fertilization, Fertility and Sterility, 72, 1018, 10.1016/S0015-0282(99)00423-9
Leroy, 1995, A single injection of GnRH antagonist (Cetrorelix) postpones the LH surge: further evidence for the role of GnRH during the LH surge, Fertility and Sterility, 62, 461, 10.1016/S0015-0282(16)56932-5
Levy, 1993, Another look at cotreatment with growth hormone and human menopausal gonadotropins in poor responders, Human Reproduction, 8, 834, 10.1093/oxfordjournals.humrep.a138150
Licciardi, 1995, Day 3 estradiol serum concentrations as prognosticators of stimulation response and pregnancy outcome in patients undergoing in vitro fertilization, Fertility and Sterility, 64, 991, 10.1016/S0015-0282(16)57916-3
Lindheim, 1996, Short-term gonadotropin suppression with oral contraceptives benefits poor responders prior to controlled ovarian hyperstimulation, Journal of Assisted Reproduction and Genetics, 16, 745, 10.1007/BF02066431
Loverro, 2003, Evaluation of functional ovarian reserve in 60 patients. Evaluation of functional ovarian reserve in 60 patients, Reproductive BioMedicine Online, 7, 200, 10.1016/S1472-6483(10)61752-X
Manzi, 1994, The value of increasing the dose of human menopausal gonadotropins in women who initially demonstrate a poor response, Fertility and Sterility, 62, 251, 10.1016/S0015-0282(16)56874-5
Martinez, 2002, Women with poor response to IVF have lowered circulating gonadotrophin surge-attenuating factor (GnSAF) bioactivity during spontaneous and stimulated cycles, Human Reproduction, 17, 634, 10.1093/humrep/17.3.634
Meredith, 1985, Role of decreased numbers of follicles on reproductive performance in young and aged rats, Biology of Reproduction, 32, 788, 10.1095/biolreprod32.4.788
Meyer, 1990, Evidence of gonadal and gonadotropin antibodies in women with a suboptimal ovarian response to exogenous gonadotropin, Obstetrics and Gynecology, 75, 795
Morgia, 2004, A controlled trial of natural cycles versus microdose gonadotropin-releasing hormone analog flare cycles in poor responders undergoing in vitro fertilization, Fertility Sterility, 81, 1542, 10.1016/j.fertnstert.2003.11.031
Muasher, 1988, The value of basal and/or stimulated serum gonadotropin levels in prediction of stimulation response and in vitro fertilization outcome, Fertility and Sterility, 50, 298, 10.1016/S0015-0282(16)60077-8
Nargund, 1995, The impact of ovarian cystectomy on ovarian response to stimulation during in-vitro fertilization cycles, Human Reproduction, 17, 1207
Navot, 1987, Prognostic assessment of female fecundity, Lancet, 1, 645, 10.1016/S0140-6736(87)92439-1
Nikolaou, 2003, Early ovarian ageing: a hypothesis, Human Reproduction, 18, 1137, 10.1093/humrep/deg245
Out, 1996, Recombinant follicle stimulating hormone (rFSH; Puregon) in assisted reproduction: more oocytes, more pregnancies. Results from five comparative studies, Human Reproduction Update, 2, 162, 10.1093/humupd/2.2.162
Padilla, 1991, The lupron screening test: tailoring the use of leuprolide acetate in ovarian stimulation for in vitro fertilization, Fertility and Sterility, 56, 79, 10.1016/S0015-0282(16)54421-5
Padilla, 1996, Use of the flare-up protocol with high dose follicle stimulating hormone and human menopausal gonadotropins for in vitro fertilization in poor responders, Fertility and Sterility, 65, 796, 10.1016/S0015-0282(16)58216-8
Pelinck, 2002, Efficacy of natural cycle IVF: a review of the literature, Human Reproduction Update, 8, 129, 10.1093/humupd/8.2.129
Pellicer, 1994, Aetiological factors involved in the low response to gonadotrophins in infertile women with normal basal serum follicle stimulating hormone levels, Human Reproduction, 9, 806, 10.1093/oxfordjournals.humrep.a138600
Pellicer, 1998, Evaluation of the ovarian reserve in young low responders with normal basal levels of follicle-stimulating hormone using three-dimensional ultrasonography, Fertility and Sterility, 70, 671, 10.1016/S0015-0282(98)00268-4
Peñarrubia, 2004, Initial analysis of variability among basal hormone biomarkers of ovarian reserve, Reproductive BioMedicine Online, 8, 191, 10.1016/S1472-6483(10)60515-9
Penzias, 2004, Improving results with assisted reproductive technologies: individualized patient-tailored strategies for ovulation induction, Reproductive BioMedicine Online, 9, 43, 10.1016/S1472-6483(10)62108-6
Perez Mayorga, 2000, Ovarian response to to FSH stimulation depends on the FSH receptor genotype, Journal of Clinical Endocrinology and Metabolism, 85, 3365, 10.1210/jc.85.9.3365
Peters, 1976, Intrauterine gonadal development, Fertility and Sterility, 27, 493, 10.1016/S0015-0282(16)41829-7
Pinkas, 2000, Gonadotropin stimulation following GnRH-a priming for poor responders in in vitro fertilization-embryo transfer program, Gynecological Endocrinology, 14, 11, 10.3109/09513590009167654
Polani, 1991, A test of the production line hypothesis of mammalian oogenesis, Human Genetics, 88, 64, 10.1007/BF00204931
Raga, 1999, Recombinant FSH stimulation in poor responders with normal basal concentration of FSH: improved reproductive outcome, Human Reproduction, 14, 1431, 10.1093/humrep/14.6.1431
Roberts, 1995, Increase in the rate of diploidy with maternal age in unfertilized in-vitro fertilization oocytes, Human Reproduction, 10, 2139, 10.1093/oxfordjournals.humrep.a136249
Rombauts, 1998, Recruitment of follicles by recombinant human follicle-stimulating hormone commencing in the luteal phase of the ovarian cycle, Fertility and Sterility, 69, 665, 10.1016/S0015-0282(98)00018-1
Rongieres-Bertrand, 1999, Revival of the natural cycles in in-vitro fertilization with the use of a new gonadotrophin-releasing hormone antagonist (Cetrorelix): a pilot study with minimal stimulation, Human Reproduction, 14, 683, 10.1093/humrep/14.3.683
Salat-Baroux, 1993, Comparison of growth hormone responses to growth hormone-releasing factor and clonidine in women with normal or poor ovarian response to gonadotropin stimulation, Fertility and Sterility, 60, 791, 10.1016/S0015-0282(16)56278-5
Schachter, 2001, Improvement of IVF outcome in poor responders by discontinuation of GnRH analogue during the gonadotropin stimulation phase – a function of improved embryo quality, Journal of Assisted Reproduction and Genetics, 18, 197, 10.1023/A:1009476411762
Schoolcraft, 1997, Improved controlled ovarian hyperstimulation in poor responder in vitro fertilization patients with a microdose follicle-stimulating hormone flare, growth hormone protocol, Fertility and Sterility, 67, 93, 10.1016/S0015-0282(97)81862-6
Scott, 1994, Enhancement of ovarian responsiveness with microdoses of gonadotropin-releasing hormone agonists during ovulation induction for in vitro fertilization, Fertility and Sterility, 61, 880, 10.1016/S0015-0282(16)56700-4
Scott, 1989, Follicle-stimulating hormone levels on cycle day 3, are predictive of in vitro fertilization outcome, Fertility and Sterility, 51, 651, 10.1016/S0015-0282(16)60615-5
Scott, 1990, Intercycle variability of day 3 follicle stimulating hormone levels and its effect on stimulation quality in in vitro fertilization and embryo transfer, Fertility and Sterility, 54, 297, 10.1016/S0015-0282(16)53707-8
Scott, 1993, A prospective evaluation of clomiphene citrate challenge test screening of the general infertility population, Obstetrics and. Gynecology, 82, 539, 10.1097/00006250-199310000-00013
Scott, 1995, Life table analysis of pregnancy rates in a general infertility population relative to ovarian reserve and patient age, Human Reproduction, 10, 1706, 10.1093/oxfordjournals.humrep.a136159
Seifer, 1997, Day 3 serum inhibin-B is predictive of assisted reproductive technologies outcome, Fertility and Sterility, 67, 110, 10.1016/S0015-0282(97)81865-1
Serafini, 1988, An alternate approach to controlled ovarian hyperstimulation in ‘poor responders’: pretreatment with a gonadotropin-releasing hormone analog, Fertility and Sterility, 49, 90, 10.1016/S0015-0282(16)59655-1
Shaller, 1992, Absence of effect of adjuvant growth hormone therapy on follicular responses to exogenous gonadotropins in women: normal and poor responders, Fertility and Sterility, 58, 919, 10.1016/S0015-0282(16)55435-1
Shapiro D, Carter M, Mitchell-Leef D, Wininger D 2002 Plateau or drop in estradiol (oestradiol) on the day after initiation of the GnRH antagonist Antagon™ in in vitro fertilization (IVF) treatment cycles does not affect pregnancy outcome. Fertility and Sterility 78 (suppl. 1): S22.
Smitz, 1992, The effect of gonadotrophin-releasing hormone (GnRH) agonist in the follicular phase on in-vitro fertilization outcome in normo-ovulatory women, Human Reproduction, 7, 1098, 10.1093/oxfordjournals.humrep.a137800
Smotrich, 1995, Prognostic value of day 3 estradiol on in vitro fertilization outcome, Fertility and Sterility, 64, 1136, 10.1016/S0015-0282(16)57974-6
Suikkari, 1996, Double-blind placebo controlled study: human biosynthetic growth for assisted reproductive technology, Fertility and Sterility, 65, 800, 10.1016/S0015-0282(16)58217-X
Surrey, 1998, Clinical and endocrine effects of a microdose GnRH agonist flare regimen administered to poor responders who are undergoing in vitro fertilization, Fertility and Sterility, 69, 419, 10.1016/S0015-0282(97)00575-X
Tarin, 1995, Aetiology of age-associated aneuploidy: a mechanism based on the ‘free radical theory of ageing’, Human Reproduction, 10, 1563, 10.1093/HUMREP/10.6.1563
Te Velde, 2002, The variability of female reproductive ageing, Human Reproduction Update, 8, 141, 10.1093/humupd/8.2.141
Toner, 1991, Basal follicle-stimulating hormone is a better predictor of in vitro performance than age, Fertility and Sterility, 55, 784, 10.1016/S0015-0282(16)54249-6
Toth, 1996, Suppression and flare regimens of gonadotropin-releasing hormone agonist: use in women with different basal gonadotropin values in an in vitro fertilization program, Journal of Reproductive Medicine, 41, 321
Treloar, 1981, Menstrual cyclicity and the perimenopause, Maturitas, 3, 49, 10.1016/0378-5122(81)90032-3
Tulandi, 2002, Ovarian reserve after uterine artery embolization for leiomyomata, Fertility and Sterility, 78, 197, 10.1016/S0015-0282(02)03164-3
Ubaldi, 2004, Natural cycles with minimal stimulation in poor responder patients: cost-effectiveness analysis, Human Reproduction, 19, O-008
Ulug, 2003, Conception rates following assisted reproduction in poor responder patients: a retrospective study in 300 consecutive cycles, Reproductive BioMedicine Online, 6, 439, 10.1016/S1472-6483(10)62164-5
van Blerkom, 1997, The developmental potential of the human oocyte is related to the dissolved oxygen content of follicular fluid: association with vascular endothelial growth factor levels and perifollicular blood flow characteristics, Human Reproduction, 12, 1047, 10.1093/humrep/12.5.1047
van Hooff, 1993, Doubling the human menopausal gonadotrophin dose in the course of an in-vitro fertilization treatment cycle in low responders: a randomized study, Human Reproduction, 8, 369, 10.1093/oxfordjournals.humrep.a138053
van Noord, 1997, Age at natural menopause in a population-based screening cohort: the role of menarche, fecundity and lifestyle factors, Fertility and Sterility, 68, 95, 10.1016/S0015-0282(97)81482-3
van Rooij, 2003, Women older than 40 years of age and those with elevated follicle-stimulating hormone levels differ in poor response rate and embryo quality in in vitro fertilization, Fertility and Sterility, 79, 482, 10.1016/S0015-0282(02)04839-2
Warburton, 1989, The effect of maternal age on the frequency of trisomy: change in meiosis or in utero selection?, Progress in Clinical and Biological Research, 311, 165
Welt, 1999, Female reproductive aging is marked by decreased secretion of dimeric inhibin, Journal of Clinical Endocrinology and Metabolism, 84, 105, 10.1210/jc.84.1.105